A study proves the connection between inflammatory markers and the increase of frailty in prostate cancer patients
- Press Office
- November 9th, 2020

Experts from the Universitat de València and the Valencian Institute of Oncology (IVO) have proved how some inflammatory markers measured in the blood are related to the progression of the frailty syndrome in prostate cancer patients, the most common tumour in men.
Categories: Facultat de Farmàcia , Investigació a la UV
Other News

The constructed wetlands of La Pipa and L’Illa reduce pesticide and heavy metal pollution in the Albufera of Valencia

Scientists develop AI tool to read the “code” of bacterial viruses and design personalised phage treatments

I2SysBio researchers propose how to bridge the gap between the origin of life and the metabolism of the last universal common ancestor